4,560
Participants
Start Date
December 3, 2004
Primary Completion Date
March 25, 2011
Study Completion Date
January 22, 2018
exemestane
one 25 mg tablet daily in am
Montefiore Medical Center, The Bronx
Centre Francois Baclesse, Caen
The George Washington University, Washington D.C.
MedStar Health Research Institute, Hyattsville
Suburban Hospital Cancer Program, Bethesda
Kinston Medical Specialists, Kinston
CHU-Hopital A. Morvan, Brest
Georgia Cancer Specialists, Tucker
Mayo Clinic Jacksonville, Jacksonville
University of Miami School of Medicine, Miami
CHU - Hopital Arnaud de Villeneuve, Montpellier
Jefferson Clinic, P.C., Birmingham
Centre Rene Gauducheau, Nantes
University of Cincinnati, Barrett Cancer Centre, Cincinnati
Indiana University Medical Center, Indianapolis
William Beaumont Hospital, Royal Oak
Hutzel Women's Health Specialists, Detroit
CRLCC - Paul Papin, Angers
Institut Jean Godinot, Reims
Medical College of Wisconsin, Milwaukee
Univ. of Wisconsin Center for Women's Health and, Madison
Centre Alexis Vautrin, Vandœuvre-lès-Nancy
Mayo Clinic Rochester, Rochester
Loyola University Medical Centre, Maywood
John H. Stroger, Jr Hospital of Cook County, Chicago
Mercy Hospital and Medical Center, Chicago
Trinity Medical Center, Moline
Mid-Illinois Hematology and Oncology Associates, Ltd., Normal
Carle Cancer Centre, Urbana
Washington University School of Medicine, St Louis
University of Oklahoma, Oklahoma City
AP-HP Hopital Tenon, Paris
Centre Henri Becquerel, Rouen
CHU de Limoges - Hopital Mere Enfant, Limoges
Los Angeles Biomedical Research Institute, Torrance
University of California, San Diego, La Jolla
Clinique Hartmann, Neuilly-sur-Seine
Centre Rene Huguenin, Saint-Cloud
Institut Gustave-Roussy, Villejuif
University of California at Davis, Sacramento
Providence Alaska Medical Center, Anchorage
UAB Comprehensive Cancer Center-LNB 301, Birmingham
University of Connecticut Health Center, Farmington
Whittingham Cancer Center at Norwalk Hospital, Norwalk
The University of Chicago Medical Center, Chicago
University of Kansas Medical Center, Kansas City
Maine Center for Cancer Medicine and Blood Disorders, Scarborough
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
University of Medicine and Dentistry of New Jersey, Newark
Abramson Cancer Center of the, Philadelphia
The Memorial Hospital of Rhode Island, Pawtucket
Fletcher Allen Health Care, Burlington
Fred Hutchinson Cancer Research Center, Seattle
BCCA - Cancer Centre for the Southern Interior, Kelowna
BCCA - Vancouver Cancer Centre, Vancouver
CancerCare Manitoba, Winnipeg
Atlantic Health Sciences Corporation, Saint John
Northeast Cancer Center Health Sciences, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
London Regional Cancer Program, London
Ottawa Health Research Institute - General Division, Ottawa
Meadowlands Family Health Centre, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Toronto East General Hospital, Toronto
Odette Cancer Centre, Toronto
Mount Sinai Hospital, Toronto
Univ. Health Network-Princess Margaret Hospital, Toronto
Women's College Hospital, Toronto
Hopital Maisonneuve-Rosemont, Montreal
CHUM - Hopital Notre-Dame, Montreal
CHUM - Pavillon Saint-Luc, Montreal
CHA-Hopital Du St-Sacrement, Québec
Orocovis Medical Center, Orocovis
Altamira Family Research Center, San Juan
Lead Sponsor
Grupo Espanol de Investigacion del Cancer de Mama
OTHER
UNICANCER
OTHER
NCIC Clinical Trials Group
NETWORK